SAVANNAH CHRISTOPHER: Open Payments
NPI 1407492572 · TULLAHOMA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 17 payments from 8 companies in 2025. Trend: 2023 $575 · 2024 $697 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Novo Nordisk Inc | 3 | $62 |
| PFIZER INC. | 3 | $58 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: Ozempic, FARXIGA, ELIQUIS, VERQUVO, JARDIANCE, LifeVest, CAMZYOS, Kerendia.
Industry payments across TN — which companies pay providers there.
